The Ketogenic diet (KD) can be found all over social media, television talk shows, and movie star blogs. An entire industry has popped up around the KD with cookbooks, special “Keto” foods, diet companies, and more. People who have tried the Ketogenic diet claim that it leads to weight loss, changes in blood sugar levels, and decreased hunger. However, the diet is very restrictive which can make it dangerous to follow without the supervision of a doctor and a registered dietitian. Keep re...
Happy March! Here is a list of our upcoming March events for patients and caregivers, free of charge. Take a look to see if we are coming to you! Texas Blood Cancer Conference 2018 3/10/18, San Antonio, TX http://www.etouches.com/TXBCC18 Surviving and Thriving With Blood Cancer 3/10/18, Cincinnati, OH http://www.lls.org/events/surviving-and-thriving-blood-cancer Living with Hodgkin Lymphoma 3/14/18, Telephone-Web Program http://www.lls.org/events/living-with-hodgkin-lym...
This month is Myeloma Awareness Month! Make sure all your bases are covered by checking out these free resources for patients and caregivers with myeloma.
Remembering Nutrition Throughout Your Cancer Journey Good nutrition is important for cancer patients. Eating the right kinds of foods can help patients feel better and stay stronger. On this episode, Alicia and Lizette speak with nutrition educator, Margaret N. Martin, RD MS LDN CDE, about dietary information to keep in mind before, during and after active treatment. Cancer and cancer treatments can affect taste, smell, appetite and the ability to eat or absorb the nutrients from food. Mar...
February 1st marks the second birthday of LLS Community! Over the years, nearly 7,000 of you have come together to support living healthy with blood cancer. We would like to take this opportunity to provide a refresher on LLS Community Guidelines. LLS Community is a positive, welcoming place for patients and caregivers at all stages of the journey. We have helped countless individuals access needed resources and engage with one another, and we count on you to help provide the safe spac...
Certain patients with chronic myeloid leukemia (CML) who take nilotinib daily may have achieved such deep remissions that they may be able to stop their treatment, according to a recent FDA decision When the targeted oral therapy, imatinib (Gleevec®) was approved by the U.S. Food & Drug Administration (FDA) in 2001, it revolutionized treatment for patients with chronic myeloid leukemia (CML), turning an almost certain death sentence into a chronic disease for most patients who r...
We’ve just concluded one of the most historic years on record in terms of new therapy approvals for blood cancers. In all, the U.S. Food and Drug Administration (FDA) approved 18 therapies to treat patients with blood cancers, including some entirely new agents and some new uses for already approved drugs. Among these approvals were the first new therapies – four to be precise – for acute myeloid leukemia (AML) after a 40-year drought in treatment advances for this deadly blood c...
After a cancer diagnosis, people with cancer and their loved ones may feel “out of step” during the holidays. A diagnosis can prompt new questions during this time, such as: How do I make this holiday feel the same as it did before my diagnosis? How do I take care of myself during the holiday rush? How can I celebrate when I have so many other things on my mind? How can I manage my fatigue during such an active time of the year? Listen to our Coping with the Holidays After Cancer epis...
Today at the #ASH17 (American Society of Hematology) conference in Atlanta, researchers presented the latest compelling data from thousands of clinical trials, revealing how experimental therapies, or approved therapies being tested in new ways, have worked in treating blood cancer patients. Among the presentations were several hundred projects across a spectrum of diseases that benefited in some way from support from The Leukemia & Lymphoma Society (LLS). While some of the results were p...
The 59th ASH (American Society of Hematology) Annual Meeting & Exposition kicks off tomorrow here in Atlanta, drawing more than 25,000 researchers, physicians, biopharmaceutical company executives, patient advocates and industry experts from around the world to share the latest scientific clinical data in the blood cancers and other blood disorders. As we do each year, LLS opened the #ASH2017 weekend by hosting our own scientific symposium today, one day before the official start of th...
